PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Otto Bock Healthcare Products GmbH

USPTO PatentsView assignee record - 64 granted patents across 25 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Otto ranks #5,392 of 49,997 tracked US assignees by granted-patent volume, with 64 patents across 25 technology areas.

#5,392
of 49,997 US assignees by volume
Top 4%
by Innovation Score (58.9/100)
15.3
avg claims per patent
+61%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5392 · Foreign Corporation #5,392 · 64 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 64 grants
  • UPPER-Q #5,392/49,997
  • PHOTO-FINISH National Products
  • CPC-FOCUS A61F · 25 areas
  • INNOV-PAR 58.9/100
  • CLAIMS-RICH 15.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +61% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Products, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Otto’s 58.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Otto

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Otto's Innovation Score is 58.9/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Otto?

Each dot is one of Otto’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Otto’s own 15.3 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Otto vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 63.964.064.06464.064.064.1 0510152025 Granted patents (volume) Avg claims / patent National Products, Inc. - 64, 18.97National ProductsNational University Corporation Yokohama National University - 64, 9.47National Universi…Nokian Tyres plc - 64, 1Nokian TyresOjjo, Inc. - 64, 9.7OjjoOxilio Ltd - 64, 19.25OxilioPaul Scherrer Institut - 64, 14.09Paul Scherrer Ins…Penumbra, Inc. - 64, 16.69PenumbraRakuten Kobo Inc. - 64, 18.39Rakuten KoboOtto Bock Healthcare Products GmbH - 64, 15.33Otto Bock Healthc…
Otto vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Otto's grants concentrate

Otto Bock Healthcare Products GmbH is a focused PatentsView assignee: 25 CPC subclasses with 78.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (13 grants) versus a trough of 3 in 2019. By volume, Otto sits between National Products, Inc. and Rakuten Kobo Inc..

Otto's three-year grant acceleration

Otto Bock Healthcare Products GmbH shows 29 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Otto's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Otto holds 64 patents at rank #5,391, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Otto

By rank, the assignees closest to #5,391 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Otto's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Otto, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Otto ranks #118 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (59 here).

Harris Corporation 59 Jvckenwood Corporation 59 L&T Technology Services Limited 59 ChemImage Corporation 59

Similar claim depth

Nearest assignees by average claims per patent (15.3 here).

Interroll Holding AG 15.3 avg Weir Minerals Australia Ltd. 15.3 avg St. Jude Children's Research Hospital, Inc. 15.3 avg Eaton Corporation 15.3 avg

Otto's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Otto Bock Healthcare Products GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 6.3%
2016 6 9.4%
2017 4 6.3%
2018 6 9.4%
2019 3 4.7%
2020 3 4.7%
2021 5 7.8%
2022 8 12.5%
2023 8 12.5%
2024 13 20.3%
2025partial year 4 6.3%

Which technologies does Otto Bock Healthcare Products GmbH patent most?

Top 15 of 25 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Otto Bock Healthcare Products GmbH's patent record in context - here's where to go next.

  • Otto Bock Healthcare Products GmbH's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 78.1% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #5,392 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Otto Bock Healthcare Products GmbH against National Products, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 58.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.